Abstract:A series of 11-substituted 3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones were obtained via hetero-Diels-Alder reaction of 5-alkyl/arylallylidene/-4-thioxo-2-thiazolidinones and 1,4-naphthoquinones. The structures of newly synthesized compounds were established by spectral data and a single-crystal X-ray diffraction analysis. According to U.S. NCI protocols, compounds 3.5 and 3.6 were screened for their anticancer activity; 11-Phenethyl-3,11-dihydro-2H-benzo[6,7]thiochromeno[… Show more
“…The acute monocytic leukemia patient‘s THP‐1 cells, which were isolated monocytes from peripheral blood, also responded favorably to treatment with 183 . This substance‘s IC 50 was 7.94 μM [48] …”
Section: The Sixth Decade Commences (2021 Till Date)mentioning
confidence: 94%
“…This substance's IC 50 was 7.94 μM. [48] A different type of thiazole derivatives showed good activity against leukemia cell lines.…”
Leukemia affects the body‘s blood‐forming tissues, especially the bone marrow and lymphatic system. Leukemia incidence varies between communities and between pathological kinds. Many treatment modalities exist for leukemia, such as chemotherapy, targeted therapy, radiation therapy, bone marrow transplantation, immunotherapy, and the engineering of immune cells to fight leukemia. Leukemia might be treated with a variety of pharmaceuticals, the most popular of which are imatinib (Gleevec), dasatinib (Sprycel), nilotinib (Tasigna), obinutuzumab (Gazyva), venetoclax (Venclexta), and so on. Thiazole is one of the scaffolds that are actively explored in leukemia. Derivatives having the thiazole nucleus have been surfacing as potent candidates in the treatment of leukemia for quite sometime now, but a consolidated report accumulating all these ventures is absent. Numerous naturally occurring substances, including flavones, alkaloids, anabolic steroids, and vitamin B1 (thiamine), include the basic thiazole molecule. Thiazole derivatives have been researched for their possible therapeutic effects in the treatment of leukemia. Thus, this review comprising reports regarding the effect of different thiazole‐based species in leukemia is a timely effort to the best of our knowledge. This review covers the chronological development of antileukemic thiazole‐based molecules, their synthesis, biological activity, and structure–activity relationships.
“…The acute monocytic leukemia patient‘s THP‐1 cells, which were isolated monocytes from peripheral blood, also responded favorably to treatment with 183 . This substance‘s IC 50 was 7.94 μM [48] …”
Section: The Sixth Decade Commences (2021 Till Date)mentioning
confidence: 94%
“…This substance's IC 50 was 7.94 μM. [48] A different type of thiazole derivatives showed good activity against leukemia cell lines.…”
Leukemia affects the body‘s blood‐forming tissues, especially the bone marrow and lymphatic system. Leukemia incidence varies between communities and between pathological kinds. Many treatment modalities exist for leukemia, such as chemotherapy, targeted therapy, radiation therapy, bone marrow transplantation, immunotherapy, and the engineering of immune cells to fight leukemia. Leukemia might be treated with a variety of pharmaceuticals, the most popular of which are imatinib (Gleevec), dasatinib (Sprycel), nilotinib (Tasigna), obinutuzumab (Gazyva), venetoclax (Venclexta), and so on. Thiazole is one of the scaffolds that are actively explored in leukemia. Derivatives having the thiazole nucleus have been surfacing as potent candidates in the treatment of leukemia for quite sometime now, but a consolidated report accumulating all these ventures is absent. Numerous naturally occurring substances, including flavones, alkaloids, anabolic steroids, and vitamin B1 (thiamine), include the basic thiazole molecule. Thiazole derivatives have been researched for their possible therapeutic effects in the treatment of leukemia. Thus, this review comprising reports regarding the effect of different thiazole‐based species in leukemia is a timely effort to the best of our knowledge. This review covers the chronological development of antileukemic thiazole‐based molecules, their synthesis, biological activity, and structure–activity relationships.
“…Detailed anticancer screening was also reported for the adducts obtained by the reaction of the Knoevenagel adduct (of isorhodanine with aliphatic aldehydes) with 1,4naphthoquinone. 79 Scheme 47 Synthesis of thiopyrano [2,3-d]thiazoles from 4-thioxo-2-thiazolidinone incorporating an arylsulfonate moiety.…”
Section: Reviewmentioning
confidence: 99%
“…Detailed anticancer screening was also reported for the adducts obtained by the reaction of the Knoevenagel adduct (of isorhodanine with aliphatic aldehydes) with 1,4-naphthoquinone. 79…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.